Post-earnings recap
Reported
Wed, May 8, 2024
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
50%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Core Scientific's strong EPS performance significantly exceeded expectations, leading to a 2.96% increase in stock price. The company did not provide revenue figures or future guidance, which may leave investors cautious. However, the substantial EPS surprise indicates potential operational strengths that could benefit the company moving forward.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.78 | N/A | +1460.00% |
| Revenue | N/A | N/A | N/A |
Management expressed satisfaction with the EPS results, highlighting operational efficiencies. They emphasized a commitment to future growth despite not providing specific revenue guidance.
We are pleased with our EPS performance this quarter.
While we did not provide revenue figures, we are focused on long-term growth.